Derivative exercise or conversion — not an open-market buy.
Traded Sep 28, 2026 · Filed Sep 30, 2026
The boss of Chemed sold $1.03M of Chemed shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,026,900
Shares × reported transaction price
62 days after results of Jul 28, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $514.30 on Sep 28, 2026, 40% above its 52-week low and 7% below its high, after a 3% drop over the previous 30 trading days
52-week range $368.59 (Mar 27, 2026) to $552.72 (Aug 7, 2026), 79% of the way up, from 246 adjusted closes. 30 trading days earlier: $532.88 on Aug 14, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Derivative exercise or conversion — not an open-market buy.